Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/12/25 → 1/12/30 |
Clinical Trial Phase
- Phase II
- Phase III (a & b)
- External Sponsor
A Phase 2/3, multicenter, randomized open-label study of zanzalintinib vs everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors
- Lau, David (Primary Chief Investigator (PCI))
Project: Research